Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP7083975B2 - Antibacterial composition, bone regeneration material containing antibacterial composition, and method for producing the same. - Google Patents
[go: Go Back, main page]

JP7083975B2 - Antibacterial composition, bone regeneration material containing antibacterial composition, and method for producing the same. - Google Patents

Antibacterial composition, bone regeneration material containing antibacterial composition, and method for producing the same. Download PDF

Info

Publication number
JP7083975B2
JP7083975B2 JP2018108486A JP2018108486A JP7083975B2 JP 7083975 B2 JP7083975 B2 JP 7083975B2 JP 2018108486 A JP2018108486 A JP 2018108486A JP 2018108486 A JP2018108486 A JP 2018108486A JP 7083975 B2 JP7083975 B2 JP 7083975B2
Authority
JP
Japan
Prior art keywords
antibacterial composition
silver
calcium carbonate
bone regeneration
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018108486A
Other languages
Japanese (ja)
Other versions
JP2019210251A (en
Inventor
守 相澤
みちよ 本田
倫啓 横田
真結 上田
昌士 牧田
直也 大坂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji University
Original Assignee
Meiji University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji University filed Critical Meiji University
Priority to JP2018108486A priority Critical patent/JP7083975B2/en
Publication of JP2019210251A publication Critical patent/JP2019210251A/en
Application granted granted Critical
Publication of JP7083975B2 publication Critical patent/JP7083975B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

本発明は、銀を担持した炭酸カルシウム粒子からなる抗菌性組成物、抗菌性組成物を含む骨再生用材料、およびその製造方法に関する。 The present invention relates to an antibacterial composition composed of calcium carbonate particles carrying silver, a bone regeneration material containing the antibacterial composition, and a method for producing the same.

インプラント材料を患部に埋め込む外科的手術作業を行った際、細菌を原因とする術後感染が生じる恐れがある。そのための対策として、患部に抗生剤を投与する他、インプラント材料自体に抗菌性を持たせる試みが行われている。 Bacterial postoperative infections may occur when performing surgical procedures to implant implant material into the affected area. As a countermeasure for this, in addition to administering an antibiotic to the affected area, attempts have been made to make the implant material itself have antibacterial properties.

近時、生分解性繊維にβ-リン酸三カルシウム(β-TCP)、ハイドロキシアパタイト(HAp)等のリン酸カルシウム化合物の粒子を含有させ、生体内にインプラントされた後に生分解性繊維の分解吸収と共にリン酸カルシウムを溶出させて骨形成を促進するタイプの骨再生材料が提案されている(特許第6039076号等)。このタイプの骨再生用インプラント材料に抗菌性を持たせる方法として、生分解性繊維に含有されたリン酸カルシウム粒子に銀を担持させて、体内で生分解性繊維が分解されてリン酸カルシウム粒子が溶解されると共に担持されていた銀が溶出されて抗菌性を発揮するという設計が提案されている(Flexible, silver containing nanocomposites for the repair of bone defects: antimicrobial effect against E. coli infection and comparison to tetracycline、Journal of Materials Chemistry 2008 Oliver D. Schneider et al.等) Recently, biodegradable fibers contain particles of calcium phosphate compounds such as β-tricalcium phosphate (β-TCP) and hydroxyapatite (HAp), and after being implanted in vivo, the biodegradable fibers are decomposed and absorbed. A type of bone regeneration material that elutes calcium phosphate and promotes bone formation has been proposed (Patent No. 6039076, etc.). As a method of giving antibacterial properties to this type of bone regeneration implant material, silver is carried on calcium phosphate particles contained in biodegradable fibers, and the biodegradable fibers are decomposed in the body to dissolve the calcium phosphate particles. A design has been proposed in which the silver carried along with it is eluted to exert antibacterial properties (Flexible, silver containing nanocomposites for the repair of bone defects: antimicrobial effect against E. coli infection and comparison to tetracycline, Journal of Materials). Chemistry 2008 Oliver D. Schneider et al. Etc.)

銀は広い抗菌スペクトルを有する優れた抗菌性金属であり、様々な種類の材料の抗菌処理に広く用いられている。銀の抗菌性の正確なメカニズムは未だ解明されていないが、Ag+イオンには強力な殺菌作用があることが知られている。近時、粒子のサイズが直径100nm以下の銀ナノ粒子が抗菌性を有することが報告されている。銀ナノ粒子が抗菌性を発揮する理由は未だ解明されておらず、銀ナノ粒子が金属状態で細菌を攻撃するという可能性と、銀ナノ粒子が溶液中で一部イオン化して細菌を攻撃するという可能性が指摘されている(銀ナノ粒子担持抗菌繊維における銀化学状態の解析 2016年3月9日(水)愛知県名古屋市「あいちシンクトロ光センター成果発表会」清野他)。銀イオンと銀ナノ粒子の生体への影響度合いを比較すると、銀イオンは、銀ナノ粒子よりも低濃度で細胞の死滅を引き起こすという実験結果が報告されている(フォーラム2008:衛生薬学・環境トキシコロジー 2008.10.17(熊本)三浦伸彦他)。 Silver is an excellent antibacterial metal with a broad antibacterial spectrum and is widely used for antibacterial treatment of various types of materials. The exact mechanism of silver's antibacterial properties has not yet been elucidated, but Ag + ions are known to have a strong bactericidal effect. Recently, it has been reported that silver nanoparticles having a particle size of 100 nm or less have antibacterial properties. The reason why silver nanoparticles exert antibacterial properties has not been clarified yet, and the possibility that silver nanoparticles attack bacteria in a metallic state and that silver nanoparticles partially ionize in solution to attack bacteria. (Analysis of silver chemical state in antibacterial fibers carrying silver nanoparticles March 9, 2016 (Wednesday) Nagoya City, Aichi Prefecture "Aichi Synctro Hikari Center Achievement Presentation" Kiyono et al.). Comparing the degree of influence of silver ions and silver nanoparticles on the living body, experimental results have been reported that silver ions cause cell death at a lower concentration than silver nanoparticles (Forum 2008: Sanitary Pharmacy / Environmental Toxicology). 2008.10.17 (Kumamoto) Nobuhiko Miura et al.).

銀を担持させたカルシウム化合物の粒子を生分解性繊維に含有させたタイプの骨再生用インプラント材料を生体内に埋め込んだ後、生分解性樹脂が体液によって加水分解され、もしくは破骨細胞によりカルシウム化合物が溶解・分解されると、カルシウム化合物に担持されていた銀が溶出する。溶出された銀金属又はそのAg+イオンは細菌を死滅させる抗菌性を有するが、同時に、増殖する必要がある骨芽細胞や周辺の細胞に対して細胞毒性を発揮する可能性がある。従って、細胞毒性の発現を抑えるためには、カルシウム化合物から溶出される銀の量は一定レベル以下に制御されなければならない。抗菌性と細胞毒性とはトレードオフの関係にあるため、銀の最適な担持量の選定は重要である。 After implanting a type of bone regeneration implant material in which particles of a calcium compound carrying silver are contained in biodegradable fibers in a living body, the biodegradable resin is hydrolyzed by body fluid or calcium is formed by osteoclasts. When the compound is dissolved and decomposed, the silver carried on the calcium compound is eluted. The eluted silver metal or its Ag + ions have antibacterial properties that kill bacteria, but at the same time may be cytotoxic to osteoblasts and surrounding cells that need to proliferate. Therefore, in order to suppress the development of cytotoxicity, the amount of silver eluted from the calcium compound must be controlled below a certain level. Since there is a trade-off between antibacterial properties and cytotoxicity, it is important to select the optimum carrying amount of silver.

さらに、上述したタイプの骨再生用インプラント材料では、体内でカルシウム化合物が溶解される過程で銀が溶出されるので、術後抗菌性を発現させるためには、体内にインプラントされた後、カルシウム化合物が溶解される必要がある。β-TCPは優れた骨形成能を有するが、体液に接して溶解する速度が遅いので、銀を担持させる相手方カルシウム化合物がβ-TCPであると抗菌性の発現は遅くなる。 Furthermore, in the above-mentioned type of bone regeneration implant material, silver is eluted in the process of dissolving the calcium compound in the body. Therefore, in order to develop postoperative antibacterial properties, the calcium compound must be implanted in the body and then the calcium compound. Needs to be dissolved. Although β-TCP has excellent bone-forming ability, it dissolves slowly in contact with body fluids, so that the expression of antibacterial activity is delayed when the partner calcium compound carrying silver is β-TCP.

特許5179124号公報Japanese Patent No. 5179124

Flexible, silver containing nanocomposites for the repair of bone defects: antimicrobial effect against E. coli infection and comparison to tetracycline、Journal of Materials Chemistry 2008 Oliver D. Schneider et al.Flexible, silver containing nanocomposites for the repair of bone defects: antimicrobial effect against E. coli infection and comparison to tetracycline, Journal of Materials Chemistry 2008 Oliver D. Schneider et al. 「銀ナノ粒子担持抗菌繊維における銀化学状態の解析」 2016年3月9日(水)愛知県名古屋市「あいちシンクトロ光センター成果発表会」清野他"Analysis of silver chemical state in silver nanoparticle-supported antibacterial fiber" March 9, 2016 (Wednesday) Nagoya City, Aichi Prefecture "Aichi Synctro Hikari Center Achievement Presentation" Kiyono et al. 「銀ナノ粒子の生体影響評価」フォーラム2008:衛生薬学・環境トキシコロジー 2008.10.17(熊本)三浦伸彦他"Biological Impact Assessment of Silver Nanoparticles" Forum 2008: Hygiene Pharmacy / Environmental Toxicology 2008.10.17 (Kumamoto) Nobuhiko Miura et al.

以上のような状況下で、骨再生用材料に含有させて、骨再生用材料が体内にインプラントされた後カルシウム化合物の分解吸収に伴い抗菌性を早期に発揮し、尚且つ細胞毒性を発現する恐れの少ない安全性の高い銀系抗菌性組成物が求められていた。 Under the above circumstances, it is contained in the bone regeneration material, and after the bone regeneration material is implanted in the body, it exhibits antibacterial properties at an early stage along with the decomposition and absorption of calcium compounds, and also exhibits cytotoxicity. There has been a demand for a highly safe silver-based antibacterial composition with less fear.

本発明の発明者等は、上記課題を解決するために、銀を担持させる相手方として炭酸カルシウムを用いることを着想した。炭酸カルシウムは安価であり、生体親和性が高い材料である。また、生体内で分解吸収される速度が速いので、担持した銀を早期に溶出することが期待できる。この着想に基づいて、本発明の発明者等は、酢酸カルシウム溶液に白色沈殿の生成を防ぐための硝酸を加え、そのあとに硝酸銀溶液を加えて調製した試料溶液を超音波噴霧熱分解法にかけたところ、硝酸銀溶液の銀イオンのほとんどは炭酸イオンと化合することなく、合成された中空形状のカルサイト相炭酸カルシウム粒子の表面に銀ナノ粒子として析出していることを発見した。 The inventors of the present invention have conceived to use calcium carbonate as a partner for supporting silver in order to solve the above-mentioned problems. Calcium carbonate is an inexpensive material with high biocompatibility. In addition, since the rate of decomposition and absorption in the living body is high, it can be expected that the carried silver will be eluted at an early stage. Based on this idea, the inventors of the present invention added nitric acid to prevent the formation of a white precipitate in a calcium acetate solution, and then added a silver nitrate solution to prepare a sample solution, which was subjected to an ultrasonic spray thermal decomposition method. As a result, it was found that most of the silver ions in the silver nitrate solution were not combined with the carbonate ions and were precipitated as silver nanoparticles on the surface of the synthesized hollow-shaped calcite phase calcium carbonate particles.

上記発見に基づき、本発明の発明者等は、さらに検討を重ねた結果、超音波噴霧熱分解法を用いて合成した銀ナノ粒子担持炭酸カルシウム粒子を抗菌性無機フィラー(抗菌性組成物)として用いることに想到した。本発明の抗菌性組成物は、炭酸カルシウムが生体液に接すると溶解・分解される速度が速いので、担持した銀ナノ粒子を早期に溶出する。銀ナノ粒子からの銀イオンの溶出濃度にもよるが、銀ナノ粒子が細胞を死滅させる濃度は、銀イオンが細胞を死滅させる濃度と比べてかなり低い(非特許文献3参照)ので、インプラント後に溶出した銀ナノ粒子が細胞毒性を生じる恐れは少ないと考えられる。この想到に基づいて、本発明の発明者等は、銀ナノ粒子が担持された炭酸カルシウム粒子(カルサイト相)を生分解性繊維に含有させれば、生分解性繊維の分解、炭酸カルシウムの溶解・分解、銀ナノ粒子の溶出という工程を経ることによって、早期に抗菌性を発揮させることができ、尚且つ、その場合銀ナノ粒子の溶出量が一定程度以下である限り、細胞毒性を発現する恐れが少ないことを見出して、本発明に至った。 Based on the above findings, the inventors of the present invention, as a result of further studies, use silver nanoparticles-supported calcium carbonate particles synthesized by the ultrasonic spray thermal decomposition method as an antibacterial inorganic filler (antibacterial composition). I came up with the idea of using it. Since the antibacterial composition of the present invention has a high rate of dissolution and decomposition when calcium carbonate comes into contact with a biological liquid, the carried silver nanoparticles are eluted at an early stage. Although it depends on the elution concentration of silver ions from silver nanoparticles, the concentration at which silver nanoparticles kill cells is considerably lower than the concentration at which silver ions kill cells (see Non-Patent Document 3), so that after implanting It is considered unlikely that the eluted silver nanoparticles will cause cytotoxicity. Based on this idea, the inventors of the present invention can decompose biodegradable fibers and calcium carbonate by incorporating calcium carbonate particles (calcite phase) carrying silver nanoparticles into the biodegradable fibers. By going through the steps of dissolution / decomposition and elution of silver nanoparticles, antibacterial properties can be exhibited at an early stage, and in that case, cytotoxicity is exhibited as long as the elution amount of silver nanoparticles is below a certain level. We have found that there is little risk of calcium carbonate, and have arrived at the present invention.

本発明の抗菌性組成物は、β-TCP等のリン酸カルシウムを含有する生分解性繊維からなる骨再生用材料に抗菌性無機フィラーとして補助的に添加して用いることができる。 The antibacterial composition of the present invention can be used as an auxiliary addition as an antibacterial inorganic filler to a bone regeneration material made of biodegradable fibers containing calcium phosphate such as β-TCP.

本発明の抗菌性組成物は、β-TCPに銀を担持させた銀担持β-TCP粉体と共に、生分解性繊維からなる骨再生用材料に補助的に添加する抗菌性無機フィラーとしても用いることができる。すなわち、銀担持β-TCP粒子に本発明の銀ナノ粒子担持炭酸カルシウム粒子を少量添加して調製した粉体を生分解性繊維に含有させると、β-TCPよりも埋植後の溶解が早い炭酸カルシウムから銀が早期に溶出されて、銀担持β-TCPよりも早期に抗菌性を発現する。次いで、炭酸カルシウムに遅れてβ-TCPが溶解することにより、β-TCPに担持されていた銀イオンが溶出して後期抗菌性を発現する。このシステムは、溶解性の異なる2種類の粉体(共にAgを担持)を合成して混ぜ込むことにより、早期と後期の両方の感染に対応できる可能性を持っている。 The antibacterial composition of the present invention is also used as an antibacterial inorganic filler to be supplementarily added to a bone regeneration material composed of biodegradable fibers together with silver-supported β-TCP powder in which β-TCP is supported by silver. be able to. That is, when the biodegradable fiber contains a powder prepared by adding a small amount of the silver nanoparticles-supported calcium carbonate particles of the present invention to the silver-supported β-TCP particles, the dissolution after implantation is faster than that of β-TCP. Silver is eluted early from calcium carbonate and develops antibacterial properties earlier than silver-bearing β-TCP. Then, by dissolving β-TCP later than calcium carbonate, the silver ion carried on β-TCP is eluted and the late antibacterial property is exhibited. The system has the potential to respond to both early and late infections by synthesizing and mixing two differently soluble powders (both carrying Ag).

本発明によれば、超音波噴霧熱分解法を用いて合成するので、超音波の周波数と試料溶液の界面張力を調整することによって、所望の粒径(メジアン径)の銀ナノ粒子担持炭酸カルシウム粒子を得ることができる。銀ナノ粒子担持炭酸カルシウム粒子の好ましい粒径は、それを含有させる生分解性繊維の外径(メジアン径)との関係で決まる。生分解性繊維をエレクトロスピニング法で紡糸する場合、銀ナノ粒子担持炭酸カルシウム粒子の粒径が生分解性繊維の外径と同等程度に大きいと、銀ナノ粒子担持炭酸カルシウム粒子を含有した生分解性繊維の紡糸が困難になる。生分解性繊維の外径が約30~50μm程度であれば、銀ナノ粒子担持炭酸カルシウム粒子の粒径は約0.1~10μm程度であることが好ましく、より好ましくは1~5μm程度が好ましい。 According to the present invention, since it is synthesized by using an ultrasonic spray thermal decomposition method, silver nanoparticles-supported calcium carbonate having a desired particle size (median diameter) can be obtained by adjusting the frequency of ultrasonic waves and the interfacial tension of the sample solution. Particles can be obtained. The preferable particle size of the calcium carbonate particles carrying silver nanoparticles is determined by the relationship with the outer diameter (median diameter) of the biodegradable fiber containing the silver nanoparticles. When spinning biodegradable fibers by the electrospinning method, if the particle size of the silver nanoparticles-supported calcium carbonate particles is as large as the outer diameter of the biodegradable fibers, biodegradation containing silver nanoparticles-supported calcium carbonate particles is performed. Spinning of sex fibers becomes difficult. When the outer diameter of the biodegradable fiber is about 30 to 50 μm, the particle size of the silver nanoparticles-supported calcium carbonate particles is preferably about 0.1 to 10 μm, more preferably about 1 to 5 μm. ..

本発明の銀ナノ粒子担持炭酸カルシウム粒子は中空略球状なので、軽量かつ形状的にポリマーに練りこむのに有利である。 Since the calcium carbonate particles supported by silver nanoparticles of the present invention are hollow and substantially spherical, they are lightweight and advantageous for kneading into a polymer in terms of shape.

本発明の銀ナノ粒子担持炭酸カルシウム粒子は溶液から直接合成しているため、粒子中の銀の分布が均質であり、担持される銀がナノ粒子化しているため、溶解性が高く、抗菌性の発現に有利である。銀が炭酸カルシウム粒子の表面に均質に分散していると、溶解性などの材料側の特性も均質に発現し、その結果、製品のパフォーマンスの高い再現性が得られる。 Since the silver nanoparticles-supported calcium carbonate particles of the present invention are synthesized directly from the solution, the distribution of silver in the particles is uniform, and since the supported silver is nanoparticles, it is highly soluble and antibacterial. It is advantageous for the expression of. When silver is homogeneously dispersed on the surface of calcium carbonate particles, properties on the material side such as solubility are also uniformly expressed, and as a result, high reproducibility of product performance can be obtained.

本発明の銀ナノ粒子担持炭酸カルシウム粒子の表面に析出した銀ナノ粒子の粒径は、10 nm ~ 500nmと小さい。銀ナノ粒子の粒径が小さいと比表面積が大きくなるので、銀ナノ粒子の見かけの溶解度は高くなっている。 The particle size of the silver nanoparticles precipitated on the surface of the silver nanoparticles-supported calcium carbonate particles of the present invention is as small as 10 nm to 500 nm. When the particle size of the silver nanoparticles is small, the specific surface area is large, so that the apparent solubility of the silver nanoparticles is high.

本発明の銀ナノ粒子担持炭酸カルシウム粒子を含有させる生分解性樹脂としては、ポリL乳酸(PLLA)、ポリ(ラクチド-co-グリコリド)共重合体(PLGA)を好適に用いることができる。PLGAはPLLAよりも加水分解する速度が速いので、含有する銀ナノ粒子担持炭酸カルシウム粒子を早期に溶出させるためにはより好適な樹脂である。 As the biodegradable resin containing the silver nanoparticles-supported calcium carbonate particles of the present invention, poly L-lactic acid (PLLA) and poly (lactide-co-glycolide) copolymer (PLGA) can be preferably used. Since PLGA has a higher rate of hydrolysis than PLLA, it is a more suitable resin for early elution of the contained silver nanoparticles-supported calcium carbonate particles.

本発明の超音波噴霧熱分解法で銀担持炭酸カルシウムを合成するための試料溶液と銀担持炭酸カルシウム粉体の調製方法を示す。A sample solution for synthesizing silver-supported calcium carbonate and a method for preparing silver-supported calcium carbonate powder by the ultrasonic spray pyrolysis method of the present invention are shown. 本発明の超音波噴霧熱分解法に用いる超音波噴霧熱分解装置を示す。The ultrasonic spray thermal decomposition apparatus used in the ultrasonic spray thermal decomposition method of this invention is shown. 本発明の超音波噴霧熱分解法で合成した銀を含有した炭酸カルシウム(以下Ag-CaCO3と略称することがある)の結晶相を粉末X線回折法(XRD)により測定した結果を示す。The results of measuring the crystal phase of silver-containing calcium carbonate (hereinafter sometimes abbreviated as Ag-CaCO3) synthesized by the ultrasonic spray pyrolysis method of the present invention by powder X-ray diffraction method (XRD) are shown. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3の元素分析(高周波誘導結合プラズマ発光分光法;ICP-AES)をした結果を示す。The results of elemental analysis (high frequency inductively coupled plasma emission spectroscopy; ICP-AES) of Ag-CaCO3 synthesized by the ultrasonic spray thermal decomposition method of the present invention are shown. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子の走査型電子顕微鏡(SEM)写真を示す。A scanning electron microscope (SEM) photograph of Ag-CaCO3 particles synthesized by the ultrasonic spray pyrolysis method of the present invention is shown. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子の粒度分布を示す。The particle size distribution of Ag-CaCO3 particles synthesized by the ultrasonic spray pyrolysis method of the present invention is shown. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子の比表面積を示す。The specific surface area of Ag-CaCO3 particles synthesized by the ultrasonic spray pyrolysis method of the present invention is shown. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子をHEPES Buffer に浸漬してイオンの溶出試験を実施した概要を示す。The outline of the ion elution test performed by immersing the Ag-CaCO3 particles synthesized by the ultrasonic spray pyrolysis method of the present invention in HEPES Buffer is shown. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子をHEPES Buffer に浸漬してCa2+イオンの溶出を調べた結果を示す。The results of immersing Ag-CaCO3 particles synthesized by the ultrasonic spray pyrolysis method of the present invention in HEPES Buffer and examining the elution of Ca 2+ ions are shown. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子をHEPES Buffer に浸漬してAg+イオンの溶出を調べた結果を示す。The results of immersing Ag-CaCO3 particles synthesized by the ultrasonic spray pyrolysis method of the present invention in HEPES Buffer and examining the elution of Ag + ions are shown. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子をHEPES Buffer に浸漬して実施したイオンの溶出試験の結果を最小発育阻止濃度(MIC)と比較した結果を示す。The results of the ion elution test conducted by immersing the Ag-CaCO3 particles synthesized by the ultrasonic spray pyrolysis method of the present invention in HEPES Buffer are shown in comparison with the minimum inhibitory concentration (MIC). 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子をLB培地に浸漬して得られた浸漬液に菌を播種し、培養後の菌数を測定することによって抗菌性を評価した概要を示す。The antibacterial property was evaluated by inoculating the Ag-CaCO 3 particles synthesized by the ultrasonic spray pyrolysis method of the present invention in an LB medium, inoculating the bacteria in the immersion liquid obtained, and measuring the number of bacteria after culturing. An overview is given. 本発明の超音波噴霧熱分解法で合成したAg-CaCO3粒子をLB培地に浸漬して得られた浸漬液へ播種した(1)黄色ブドウ球菌(S. aureus)と(2)大腸菌(E. coli)の培養後の菌数を測定することによって抗菌性を評価した結果を示す。(1) Staphylococcus aureus (S. aureus) and (2) Escherichia coli (E) were inoculated into the dipping solution obtained by immersing Ag-CaCO 3 particles synthesized by the ultrasonic spray thermal decomposition method of the present invention in an LB medium. The results of evaluating the antibacterial property by measuring the number of bacteria after culturing E. coli) are shown. 上記方法で作製した混練物の外観(パターンA)を示す。The appearance (pattern A) of the kneaded product prepared by the above method is shown. 上記方法で作製した綿状物の外観(パターンA)を示す。The appearance (pattern A) of the cotton-like material produced by the above method is shown. 作製した綿状物の繊維表面微細構造(低拡大, パターンA)を示す。The fiber surface microstructure (low enlargement, pattern A) of the produced cotton-like material is shown. 作製した綿状物の繊維表面微細構造(高拡大, パターンA)を示す。The fiber surface microstructure (high enlargement, pattern A) of the produced cotton-like material is shown.

以下、本発明を実施するための形態について図面を用いて説明する。 Hereinafter, embodiments for carrying out the present invention will be described with reference to the drawings.

(A)Ag-CaCO3の合成
(1) 試料溶液の調製
図1に示す所定の各量の酢酸カルシウム一水和物(CH3COO)2Ca・H2O)溶液に白色沈殿を防ぐための硝酸を加え、硝酸銀(AgNO3)溶液を混合し、試料溶液(Ag-CaCO3(0), Ag-CaCO3(1), Ag-CaCO3(5), Ag-CaCO3(10))とした。図1において、調製したサンプルは略号Ag-CaCO3(x)で表す。xはAg添加量を示す。Ag添加量[mol/%]は、Ag [mol]/CaCO3[mol] x 100 の計算式で算出した。
(A) Synthesis of Ag-CaCO 3
(1) Preparation of sample solution Add nitric acid to prevent white precipitation to each predetermined amount of calcium acetate monohydrate (CH 3 COO) 2 Ca · H 2 O) solution shown in Fig. 1, and silver nitrate (AgNO 3 ). ) Solutions were mixed to obtain sample solutions (Ag-CaCO 3 (0), Ag-CaCO3 (1), Ag-CaCO3 (5), Ag-CaCO3 (10)). In FIG. 1, the prepared sample is represented by the abbreviation Ag-CaCO3 (x). x indicates the amount of Ag added. The amount of Ag added [mol /%] was calculated by the formula of Ag [mol] / CaCO3 [mol] x 100.

(2) 超音波噴霧熱分解
図2に示す超音波噴霧熱分解装置を用いて上記の試料溶液から銀担持炭酸カルシウムを合成した。超音波により溶液を噴霧し、電気炉内で600℃の熱を加えて塩(炭酸カルシウムの前駆体)を析出させる。その塩から酢酸イオンが熱分解された結果、銀を含有した中空略球形状の炭酸カルシウム粒子が合成された。次いで、得られた粉体に洗浄処理(超純水3回、アセトン3回)を施し、1日かけて凍結乾燥した。
(2) Ultrasonic spray pyrolysis Silver-supported calcium carbonate was synthesized from the above sample solution using the ultrasonic spray pyrolysis apparatus shown in FIG. The solution is sprayed by ultrasonic waves, and heat of 600 ° C. is applied in an electric furnace to precipitate a salt (precursor of calcium carbonate). As a result of the thermal decomposition of acetate ions from the salt, hollow substantially spherical calcium carbonate particles containing silver were synthesized. Then, the obtained powder was subjected to a washing treatment (ultrapure water 3 times, acetone 3 times) and freeze-dried over 1 day.

(3) 銀ナノ粒子担持炭酸カルシウム粒子のXRD,ICP測定
上記の試料溶液AgCaCO3(0),Ag-CaCO3(1),Ag-CaCO3(5),Ag-CaCO3(10)から合成された各銀担持炭酸カルシウム粒子をXRDとICP測定した結果を図3(1)と図3(2)に示す。XRD,ICP-AES測定の結果から、合成された銀担持炭酸カルシウムはカルサイト型炭酸カルシウムと銀の混合相であった。調整された粉体の銀含有率は、仕込み溶液から期待される銀担持量とほぼ等しかった。
(3) XRD, ICP measurement of silver nanoparticles-supported calcium carbonate particles Silver synthesized from the above sample solutions AgCaCO3 (0), Ag-CaCO3 (1), Ag-CaCO3 (5), Ag-CaCO3 (10) The results of XRD and ICP measurement of the carried calcium carbonate particles are shown in FIGS. 3 (1) and 3 (2). From the results of XRD and ICP-AES measurements, the synthesized silver-bearing calcium carbonate was a mixed phase of calcite-type calcium carbonate and silver. The silver content of the adjusted powder was almost equal to the silver loading expected from the charged solution.

(4)銀ナノ粒子担持炭酸カルシウム粒子のSEM測定
上記の試料溶液Ag-CaCO3(0),Ag-CaCO3(1),Ag-CaCO3(5),Ag-CaCO3(10)から合成された各銀担持炭酸カルシウム粒子をSEM写真で撮影した結果を図4に示す。Ag-CaCO3(5),Ag-CaCO3(10)において銀はナノ粒子としてCaCO3粒子表面にほぼ均質的に分布している様子が観察された。
(4) SEM measurement of silver nanoparticle-bearing calcium carbonate particles Synthesized from the above sample solutions Ag-CaCO 3 (0), Ag-CaCO 3 (1), Ag-CaCO 3 (5), Ag-CaCO 3 (10) FIG. 4 shows the results of taking SEM photographs of each of the silver-supported calcium carbonate particles. In Ag-CaCO 3 (5) and Ag-CaCO 3 (10), it was observed that silver was distributed almost uniformly on the surface of CaCO 3 particles as nanoparticles.

(5) 銀担持炭酸カルシウム粒子の粒度分布と比表面積の測定
図5(1)に試料溶液AgCaCO3(0),Ag-CaCO3(1),Ag-CaCO3(5),Ag-CaCO3(10)から合成された各銀担持炭酸カルシウム粒子の粒度分布を示し、図5(2)に各粒子の比表面積を示す。調製した粉体のほとんどはマイクロサイズで、それぞれのメジアン径は1.8~3.5μmの範囲であったが、これは無機フィラーとしての利用に適したサイズである。
(5) Measurement of particle size distribution and specific surface area of silver-supported calcium carbonate particles From the sample solutions AgCaCO3 (0), Ag-CaCO3 (1), Ag-CaCO3 (5), Ag-CaCO3 (10) in Fig. 5 (1). The particle size distribution of each synthesized silver-supported calcium carbonate particle is shown, and FIG. 5 (2) shows the specific surface area of each particle. Most of the prepared powders were micro-sized, and the median diameter of each was in the range of 1.8 to 3.5 μm, which is a size suitable for use as an inorganic filler.

(6)イオン溶出試験
図6に、試料溶液Ag-CaCO3(0),Ag-CaCO3(1),Ag-CaCO3(5),Ag-CaCO3(10)から合成された各銀担持炭酸カルシウム粒子について実施したイオン溶出試験を示す。
試料Ag-CaCO3(0),Ag-CaCO3(1),Ag-CaCO3(5),Ag-CaCO3(10)0.1 gを秤量して、20mM HEPES Buffer (pH = 7.30)10 mL中に1日、3日、5日、7日、10日、14日、21日、28日浸漬した後、上清液中に含まれるCa,Agの濃度をICP-AESによって測定した。イオン溶出試験の結果を図7(1)と(2)に示す。試験の結果から、カルシウムは銀の含有率に関わらず、ほぼ同じ挙動で試験期間中溶け出し続けることが確認された。また、銀は(1)、(5)、(10)のどのサンプルにおいても試験期間中の溶出が確認できた。この結果から、銀担持炭酸カルシウム粒子は長期にわたって骨形成を促進し、抗菌性を発現する可能性があると考えられる。
(6) Ion elution test Fig. 6 shows each silver carrier synthesized from the sample solutions Ag-CaCO 3 (0), Ag-CaCO 3 (1), Ag-CaCO 3 (5), Ag-CaCO 3 (10). The ion elution test performed on the calcium carbonate particles is shown.
Weigh 0.1 g of sample Ag-CaCO 3 (0), Ag-CaCO 3 (1), Ag-CaCO 3 (5), Ag-CaCO 3 (10) in 10 mL of 20 mM HEPES Buffer (pH = 7.30). After soaking in 1 day, 3 days, 5 days, 7 days, 10 days, 14 days, 21 days and 28 days, the concentration of Ca and Ag contained in the supernatant was measured by ICP-AES. The results of the ion elution test are shown in FIGS. 7 (1) and 7 (2). From the results of the test, it was confirmed that calcium continued to dissolve during the test period with almost the same behavior regardless of the silver content. In addition, it was confirmed that silver was eluted during the test period in all of the samples (1), (5), and (10). From this result, it is considered that silver-supported calcium carbonate particles may promote bone formation over a long period of time and develop antibacterial properties.

(7)抗菌性評価
図8は、最小発育阻止濃度(抗菌剤が細菌の増殖を抑制する最も低い濃度)との比較で、Ag-CaCO3(1),Ag-CaCO3(5),Ag-CaCO3(10)からのイオン溶出濃度を見た結果を示す。黄色ブドウ球菌の最小発育阻止濃度は2.0ppmであるため、それ以上の結果を太字で表記した。太字表記部分の銀濃度・日数において、黄色ブドウ球菌に対して抗菌性を発現すると考えられる。
(7) Antibacterial evaluation FIG. 8 shows Ag-CaCO3 (1), Ag-CaCO3 (5), Ag-CaCO3 in comparison with the minimum inhibitory concentration (the lowest concentration at which the antibacterial agent suppresses bacterial growth). The result of observing the ion elution concentration from (10) is shown. Since the minimum inhibitory concentration of Staphylococcus aureus is 2.0 ppm, the results above that are shown in bold. It is considered that antibacterial activity is exhibited against Staphylococcus aureus at the silver concentration and the number of days in bold.

図9は、試料AgCaCO3(0),Ag-CaCO3(1),Ag-CaCO3(5),Ag-CaCO3(10)について実施した抗菌性評価試験の方法を示す。図10(1)と(2)は、試料AgCaCO3(0), Ag-CaCO3(1), Ag-CaCO3(5),Ag-CaCO3(10)について実施した抗菌性評価試験を示す。Ag-CaCO3(1), Ag-CaCO3(5), Ag-CaCO3(10)では大きく細菌の発育が抑制された。この結果は、粉体から溶出したAg+イオンによって抗菌性が発現したことを示すと考えられる。 FIG. 9 shows the method of antibacterial evaluation test performed on the samples AgCaCO 3 (0), Ag-CaCO 3 (1), Ag-CaCO 3 (5), and Ag-CaCO 3 (10). FIGS. 10 (1) and 10 (2) show antibacterial evaluation tests performed on the samples AgCaCO 3 (0), Ag-CaCO 3 (1), Ag-CaCO 3 (5), and Ag-CaCO 3 (10). .. Ag-CaCO 3 (1), Ag-CaCO 3 (5), and Ag-CaCO 3 (10) greatly suppressed the growth of bacteria. This result is considered to indicate that the antibacterial property was exhibited by the Ag + ion eluted from the powder.

(B)Ag-CaCO3を含有した生分解性繊維の製造
Ag-CaCO3(5)(濃度は「[Ag mol/ CaCO3 mol]×100」で計算されている)の粉体および、綿形状人工骨の材料である生分解性樹脂(PLLA)およびβ-TCP、ケイ素含有バテライト(SiV)を使用し、熱混練装置(ニーダー)で加熱しながら捏ね合わせた複合体(混練物)を作製する。混練物作製において、組成では重量比で「30% PLLA:40% β-TCP:24.76% SiV:5.24% Ag-CaCO3」(パターンA)および「30% PLLA:40% β-TCP:26.86% SiV:3.14% Ag-CaCO3」(パターンB)の2つの組成パターンで作製した。作製手順は、ニーダー混練槽部分の温度を190度に設定し、90分の予熱後、まずPLLAを投入した。3分30秒後、β-TCP、SiV、Ag-CaCO3の粉体を予混合したものを投入した。混練開始から9分・12分後にそれぞれ、ニーダーの混合ブレードを20秒ほど逆回転させ、よりよく混練されるようにした。混練開始から14分30秒後、混練物を回収した。図11に上記方法で作製した混練物の外観(パターンA)を示す
(B) Production of biodegradable fiber containing Ag-CaCO3
Ag-CaCO 3 (5) (concentration is calculated as "[Ag mol / CaCO 3 mol] x 100") powder and biodegradable resin (PLLA) and β, which are materials for cotton-shaped artificial bone. -Using TCP and silicon-containing batelite (SiV), knead while heating with a heat kneader (kneader) to prepare a complex (kneaded product). In the preparation of the kneaded product, the composition is "30% PLLA: 40% β-TCP: 24.76% SiV: 5.24% Ag-CaCO 3 " (Pattern A) and "30% PLLA: 40% β-TCP: 26.86%". SiV: 3.14% Ag-CaCO 3 ”(Pattern B) was prepared with two composition patterns. In the manufacturing procedure, the temperature of the kneader kneading tank was set to 190 degrees, and after 90 minutes of preheating, PLLA was first added. After 3 minutes and 30 seconds, a premixed powder of β-TCP, SiV, and Ag-CaCO 3 was added. Nine minutes and twelve minutes after the start of kneading, the kneader's mixing blade was rotated in the reverse direction for about 20 seconds to improve kneading. After 14 minutes and 30 seconds from the start of kneading, the kneaded material was collected. FIG. 11 shows the appearance (pattern A) of the kneaded product produced by the above method.

混練物を有機溶媒で溶解させ、エレクトロスピニング(ES)紡糸溶液とし、電圧をかけて吐出することにより、生分解性繊維として成形し、コレクター内に綿状に堆積させることによって、Ag-CaCO3含有生分解性繊維からなる綿状の人工骨を得る。混練物を溶解させる有機溶媒はクロロホルムであり、ES紡糸溶液の中でPLLAの濃度が重量比で8%となるよう溶液を調製した。スターラーで一晩(約15時間)回転させ、混練物をクロロホルムに溶解させたものをES紡糸溶液とし、ES装置に設置した。ES装置内にエタノールで満たしたコレクターを設置し、エタノール液面をグラウンドとして紡糸された繊維が液中に飛び込むよう調整し、エレクトロスピニングを行った。装置設定項目は、印加電圧20 kV、溶液押出速度15 mL/hr、テイラーコーンのクリーニング間隔2分であった。紡糸中のES装置内は、飛行中の繊維からの有機溶媒の揮発タイミング調整のため、温度30度以下・湿度50%未満となるようコントロールした。図12に上記方法で作製した綿状物の外観(パターンA)を示す。 Ag-CaCO 3 is formed by dissolving the kneaded material in an organic solvent to prepare an electrospinning (ES) spinning solution, forming it into biodegradable fibers by discharging it under a voltage, and depositing it in a cotton-like form in a collector. A cotton-like artificial bone made of contained biodegradable fibers is obtained. The organic solvent for dissolving the kneaded product was chloroform, and the solution was prepared so that the concentration of PLLA in the ES spinning solution was 8% by weight. The mixture was rotated overnight (about 15 hours) with a stirrer, and the kneaded product dissolved in chloroform was used as an ES spinning solution and installed in an ES device. A collector filled with ethanol was installed in the ES device, and the fibers spun with the ethanol liquid level as the ground were adjusted so that they jumped into the liquid, and electrospinning was performed. The equipment setting items were an applied voltage of 20 kV, a solution extrusion speed of 15 mL / hr, and a Taylor cone cleaning interval of 2 minutes. The inside of the ES device during spinning was controlled so that the temperature was 30 degrees or less and the humidity was less than 50% in order to adjust the volatilization timing of the organic solvent from the fibers in flight. FIG. 12 shows the appearance (pattern A) of the cotton-like material produced by the above method.

ESを行うにあたり、適切な有機溶媒を選定し、紡糸溶液の押出し量、印加電圧、紡糸溶液中の樹脂(PLLA等)濃度を調整することで、本来はナノ単位の繊維の成形方法であるES装置を使用しながらも、繊維の径を太くして30~100 μmの繊維を作製することができる。マイクロ単位の繊維は、細胞が定着するための足場となりやすく、綿形状による複雑な形状は表面積を立体的に増やし、細胞の定着・増殖性を高める狙いがある。走査型電子顕微鏡(SEM)での観察に供した結果、作製した綿状物は、綿形状人工骨充填材の特長である、30-100 μmの扁平な繊維の集合体であることが確認でき、繊維表面には、担持させた無機フィラー(β-TCP, SiV, Ag-CaCO3)が繊維表面にまんべんなく担持されていることが確認できた。図13は作製した綿状物の繊維表面微細構造(低拡大, パターンA)を示す。扁平な繊維であり、繊維径が約50μm前後であることが分かる。図14は作製した綿状物の繊維表面微細構造(高拡大, パターンA)を示す。材料である無機フィラー(β-TCP, SiV, Ag-CaCO3)が繊維表面にまんべんなく担持されていることが分かる。 When performing ES, by selecting an appropriate organic solvent and adjusting the extrusion amount of the spinning solution, the applied voltage, and the concentration of the resin (PLLA, etc.) in the spinning solution, ES, which is originally a nano-unit fiber molding method, is used. While using the device, it is possible to increase the diameter of the fiber to produce a fiber of 30 to 100 μm. Micro-unit fibers tend to serve as scaffolds for cell colonization, and the complex shape of cotton shape has the aim of increasing the surface area three-dimensionally and enhancing cell colonization and proliferation. As a result of observation with a scanning electron microscope (SEM), it was confirmed that the produced cotton-like material is an aggregate of flat fibers of 30-100 μm, which is a feature of the cotton-shaped artificial bone filler. It was confirmed that the supported inorganic fillers (β-TCP, SiV, Ag-CaCO 3 ) were evenly supported on the fiber surface. FIG. 13 shows the fiber surface microstructure (low enlargement, pattern A) of the produced cotton-like material. It can be seen that it is a flat fiber and the fiber diameter is about 50 μm. FIG. 14 shows the fiber surface microstructure (high enlargement, pattern A) of the produced cotton-like material. It can be seen that the inorganic fillers (β-TCP, SiV, Ag-CaCO 3 ), which are the materials, are evenly supported on the fiber surface.

(C)Ag-CaCO3を含有した生分解性繊維の抗菌性、細胞毒性の評価
Ag-CaCO3は濃度別にそれぞれ、コントロールの「0」、銀を含有した「1」、「5」、「10」の3パターンを作製している。濃度は「[Ag mol/ CaCO3 mol]×100」で計算されている。合成したAg-CaCO3について、X線回折(XRD)による解析では、カルサイト型炭酸カルシウムと銀の混合相であることが分かった。医療材料として用いる際、生体に有害だと考えられる「硝酸」を除去する工程として超純水およびアセトンによる洗浄を行ったが、洗浄工程後のAg-CaCO3粉体からはFT-IRにより、硝酸イオン(NO3 -)のピークは現れなかったため、硝酸の除去に成功したと考えられる。また、Ag-CaCO3粉体について、ICP-AESにより元素定量解析を行った結果、全ての銀の濃度において、期待される量の銀を担持していた。SEMによる粉体の表面形態の観察では、銀の濃度が高い場合、いびつな形になっている粒子や小さな突起がある粒子が多く観察された。
(C) Evaluation of antibacterial and cytotoxicity of biodegradable fibers containing Ag-CaCO3
For Ag-CaCO3, three patterns of control "0", silver-containing "1", "5", and "10" are prepared for each concentration. The concentration is calculated by "[Ag mol / CaCO 3 mol] x 100". Analysis of the synthesized Ag-CaCO 3 by X-ray diffraction (XRD) revealed that it was a mixed phase of calcite-type calcium carbonate and silver. When used as a medical material, it was washed with ultrapure water and acetone as a step to remove "nitric acid" which is considered to be harmful to the living body. Since the peak of ion (NO 3- ) did not appear, it is considered that the removal of nitric acid was successful. In addition, as a result of elemental quantitative analysis of Ag-CaCO3 powder by ICP-AES, the expected amount of silver was carried at all silver concentrations. In the observation of the surface morphology of the powder by SEM, when the silver concentration was high, many particles with a distorted shape and particles with small protrusions were observed.

XRD解析では、合成したAg-CaCO3に炭酸銀の生成は認められなかった。炭酸銀は溶解性が低いので、合成の過程で副生されると銀ナノ粒子担持炭酸カルシウム粒子の合成がその分抑制される。その結果、銀が炭酸銀の合成に相対的に多くとられてしまうので、抗菌性が低下してしまう。従って、超音波噴霧熱分解法を用いて炭酸銀が副生されないことは、材料の抗菌性にとってプラスに働くと考えられる。 XRD analysis showed no silver carbonate formation in the synthesized Ag-CaCO3. Since silver carbonate has low solubility, if it is produced as a by-product in the process of synthesis, the synthesis of silver nanoparticles-supported calcium carbonate particles is suppressed by that amount. As a result, silver is taken in a relatively large amount in the synthesis of silver carbonate, so that the antibacterial property is lowered. Therefore, it is considered that the fact that silver carbonate is not produced as a by-product using the ultrasonic spray pyrolysis method has a positive effect on the antibacterial properties of the material.

材料としてのAg-CaCO3の抗菌性試験では、シェーク法において「1」以上の全てのサンプルにおいて抗菌性が確認された。
細胞毒性については、Ag-CaCO3のAgは銀ナノ粒子として存在することが確認されており、銀ナノ粒子の細胞毒性は、同じ濃度の銀イオンと比べて低いので、Ag- CaCO3の材料の細胞毒性は低いと予想される。
In the antibacterial test of Ag-CaCO3 as a material, the antibacterial property was confirmed in all the samples of "1" or more in the shake method.
Regarding cytotoxicity, it has been confirmed that Ag of Ag-CaCO3 exists as silver nanoparticles, and since the cytotoxicity of silver nanoparticles is lower than that of silver ions of the same concentration, cells of the material of Ag-CaCO3 The toxicity is expected to be low.

以上、本発明を実施するための形態について説明したが、本発明はこれらに限定されるものではなく、本発明の技術的思想の範囲内で各種の変形が可能である。
銀ナノ粒子担持炭酸カルシウム粒子を含有させる骨再生用材料は生分解性繊維からなる材料に限定されるものではなく、他の成形品又は顆粒状であってもよい。
Although the embodiments for carrying out the present invention have been described above, the present invention is not limited to these, and various modifications can be made within the scope of the technical idea of the present invention.
The material for bone regeneration containing silver nanoparticles-supported calcium carbonate particles is not limited to the material made of biodegradable fibers, and may be other molded products or granules.

Claims (11)

生分解性繊維に含有する抗菌性組成物であって、
前記抗菌性組成物は、銀ナノ粒子が表面に略均質に分布して析出した中空略球状の炭酸カルシウム粒子であり、
前記抗菌性組成物のメジアン径が0.1~10μmであることを特徴とする
抗菌性組成物。
An antibacterial composition contained in biodegradable fibers.
The antibacterial composition is hollow substantially spherical calcium carbonate particles in which silver nanoparticles are distributed substantially uniformly on the surface and precipitated.
An antibacterial composition having a median diameter of 0.1 to 10 μm.
前記炭酸カルシウム粒子に含まれる炭酸カルシウムはカルサイト相である、請求項1に記載の抗菌性組成物。
The antibacterial composition according to claim 1, wherein the calcium carbonate contained in the calcium carbonate particles is a calcite phase.
前記銀ナノ粒子のメジアン径は10~500nmである、請求項1又は請求項2に記載の銀系抗菌性組成物。
The silver-based antibacterial composition according to claim 1 or 2, wherein the silver nanoparticles have a median diameter of 10 to 500 nm.
生分解性繊維に含有する抗菌性組成物の製造方法であって、

酢酸カルシウム溶液に硝酸を加えた後、硝酸銀溶液を混合して調製した試料溶液を超音波噴霧熱分解することによって、

銀ナノ粒子が表面に略均質に分布して析出した中空略球状の炭酸カルシウム粒子を合成し、
前記超音波噴霧熱分解を、前記抗菌性組成物のメジアン径が0.1~10μmとなるように調整する
抗菌性組成物の製造方法。
A method for producing an antibacterial composition contained in biodegradable fibers.

After adding nitric acid to the calcium acetate solution, the sample solution prepared by mixing the silver nitrate solution is subjected to ultrasonic spray pyrolysis.

By synthesizing hollow, substantially spherical calcium carbonate particles in which silver nanoparticles are distributed substantially uniformly on the surface and precipitated.
A method for producing an antibacterial composition, wherein the ultrasonic spray pyrolysis is adjusted so that the median diameter of the antibacterial composition is 0.1 to 10 μm.
前記炭酸カルシウムはカルサイト相である、請求項4に記載の抗菌性組成物の製造方法。
The method for producing an antibacterial composition according to claim 4, wherein the calcium carbonate is a calcite phase.
前記銀ナノ粒子のメジアン径は10~500nmである、請求項4~5のいずれか一項に記載の抗菌性組成物の製造方法。
The method for producing an antibacterial composition according to any one of claims 4 to 5, wherein the silver nanoparticles have a median diameter of 10 to 500 nm.
請求項1~3のいずれか1項に記載の抗菌性組成物を含む生分解性繊維からなる骨再生用材料であって、

前記生分解性繊維は、ポリL乳酸又はポリ(ラクチド-co-グリコリド)共重合体のうち少なくともいずれか一つとリン酸カルシウムを含み、

前記抗菌性組成物と前記リン酸カルシウムが前記生分解性繊維中に略均一に分散して含有されている、
銀ナノ粒子担持炭酸カルシウム粒子
骨再生用材料。
A material for bone regeneration comprising biodegradable fibers containing the antibacterial composition according to any one of claims 1 to 3.

The biodegradable fiber contains at least one of poly Llactic acid or a poly (lactide-co-glycolide) copolymer and calcium phosphate.

The antibacterial composition and the calcium phosphate are contained in the biodegradable fibers in a substantially uniformly dispersed manner.
Silver nanoparticles-supported calcium carbonate particles Bone regeneration material.
前記生分解性繊維の外径は、10~50μmである、
請求項7のいずれか一項に記載の骨再生用材料。
The outer diameter of the biodegradable fiber is 10 to 50 μm.
The material for bone regeneration according to any one of claims 7.
請求項1~3のいずれか1項に記載の抗菌性組成物を含む生分解性繊維からなる骨再生用材料の製造方法であって、

酢酸カルシウム溶液に硝酸を加えた後、硝酸銀溶液を混合して調製した試料溶液を超音波噴霧熱分解することによって、

銀ナノ粒子が表面に略均質に分布して析出した中空略球状の炭酸カルシウム粒子を合成し、
前記超音波噴霧熱分解を、前記抗菌性組成物のメジアン径が0.1~10μmとなるように調整し、

前記抗菌性組成物を生分解性樹脂に含有させて調製した紡糸溶液を用いて生分解性繊維を製造する、

骨再生用材料の製造方法。
A method for producing a bone regeneration material comprising biodegradable fibers containing the antibacterial composition according to any one of claims 1 to 3.

After adding nitric acid to the calcium acetate solution, the sample solution prepared by mixing the silver nitrate solution is subjected to ultrasonic spray pyrolysis.

By synthesizing hollow, substantially spherical calcium carbonate particles in which silver nanoparticles are distributed substantially uniformly on the surface and precipitated.
The ultrasonic spray pyrolysis was adjusted so that the median diameter of the antibacterial composition was 0.1 to 10 μm.

A biodegradable fiber is produced using a spinning solution prepared by containing the antibacterial composition in a biodegradable resin.

A method for manufacturing a material for bone regeneration.
前記生分解性繊維は、ポリL乳酸又はポリ(ラクチド-co-グリコリド)共重合体のうち少なくともいずれか一つとリン酸カルシウムを含む
請求項9に記載の骨再生用材料の製造方法。
The method for producing a bone regeneration material according to claim 9, wherein the biodegradable fiber contains at least one of poly L-lactic acid or a poly (lactide-co-glycolide) copolymer and calcium phosphate.
前記生分解性繊維の外径は、10~50μmである、
請求項9又は請求項10に記載の骨再生用材料の製造方法。
The outer diameter of the biodegradable fiber is 10 to 50 μm.
The method for producing a bone regeneration material according to claim 9 or 10.
JP2018108486A 2018-06-06 2018-06-06 Antibacterial composition, bone regeneration material containing antibacterial composition, and method for producing the same. Active JP7083975B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018108486A JP7083975B2 (en) 2018-06-06 2018-06-06 Antibacterial composition, bone regeneration material containing antibacterial composition, and method for producing the same.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018108486A JP7083975B2 (en) 2018-06-06 2018-06-06 Antibacterial composition, bone regeneration material containing antibacterial composition, and method for producing the same.

Publications (2)

Publication Number Publication Date
JP2019210251A JP2019210251A (en) 2019-12-12
JP7083975B2 true JP7083975B2 (en) 2022-06-14

Family

ID=68845717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018108486A Active JP7083975B2 (en) 2018-06-06 2018-06-06 Antibacterial composition, bone regeneration material containing antibacterial composition, and method for producing the same.

Country Status (1)

Country Link
JP (1) JP7083975B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015005205A1 (en) 2013-07-09 2015-01-15 国立大学法人名古屋工業大学 Bone defect filling material, and production method therefor
JP2016172656A (en) 2015-03-17 2016-09-29 太平洋セメント株式会社 Fine calcium carbonate hollow particles
WO2017029482A1 (en) 2015-08-14 2017-02-23 Imerys Minerals Limited Inorganic particulate containing antimicrobial metal

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015005205A1 (en) 2013-07-09 2015-01-15 国立大学法人名古屋工業大学 Bone defect filling material, and production method therefor
JP2016172656A (en) 2015-03-17 2016-09-29 太平洋セメント株式会社 Fine calcium carbonate hollow particles
WO2017029482A1 (en) 2015-08-14 2017-02-23 Imerys Minerals Limited Inorganic particulate containing antimicrobial metal

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DLUGOSZ Maciej, BULWAN Maria, KANIA Gabriela, NOWAKOWSKA Maria, ZAPOTOCZNY Szczepan,Hybrid calcium carbonate/polymer microparticles containing silver nanoparticles as antibacterial agents,Journal of Nanoparticle Research,2012年,14, 12,1-8
横田倫啓、本田みちよ、大坂直也、牧田昌士、西川靖俊、春日敏宏、相澤守,抗菌性を備えた銀含有リン酸カルシウム微小球の合成とその特性評価,日本バイオマテリアル学会大会予稿集,39,2017年,109

Also Published As

Publication number Publication date
JP2019210251A (en) 2019-12-12

Similar Documents

Publication Publication Date Title
Mokabber et al. Antimicrobial electrodeposited silver-containing calcium phosphate coatings
Yan et al. Preparation and characterization of chitosan-silver/hydroxyapatite composite coatings onTiO2 nanotube for biomedical applications
Mirzaee et al. Synthesis and characterization of silver doped hydroxyapatite nanocomposite coatings and evaluation of their antibacterial and corrosion resistance properties in simulated body fluid
Zhang et al. 3D-printed bioceramic scaffolds with antibacterial and osteogenic activity
Sutha et al. In-vitro bioactivity, biocorrosion and antibacterial activity of silicon integrated hydroxyapatite/chitosan composite coating on 316 L stainless steel implants
Ali et al. Thermosensitive chitosan/phosphate hydrogel-composites fortified with Ag versus Ag@ Pd for biomedical applications
Malagurski et al. Synthesis and antimicrobial properties of Zn-mineralized alginate nanocomposites
Roguska et al. Surface characterization of Ca‐P/Ag/TiO2 nanotube composite layers on Ti intended for biomedical applications
Sikder et al. Development of single-phase silver-doped antibacterial CDHA coatings on Ti6Al4V with sustained release
Swain et al. Dual action of polarised zinc hydroxyapatite-guar gum composite as a next generation bone filler material
Zhao et al. Ag-incorporated FHA coating on pure Mg: degradation and in vitro antibacterial properties
WO2021189192A1 (en) Bone tissue engineering scaffold having gradually antibacterial and bone regeneration promoting functions, manufacturing method for scaffold, and applications thereof
Mudhafar et al. Synthesis and characterization of fish scales of hydroxyapatite/collagen–silver nanoparticles composites for the applications of bone filler
Jariya et al. Drug delivery and antimicrobial studies of chitosan-alginate based hydroxyapatite bioscaffolds formed by the Casein micelle assisted synthesis
Foroutan et al. Mesoporous strontium-doped phosphate-based sol-gel glasses for biomedical applications
WO2018047130A1 (en) Implantable medical devices having a coating layer with antimicrobial properties based on nanostructured hydroxyapatite
Patty et al. The enhanced properties and bioactivity of poly-ε-caprolactone/poly lactic-co-glycolic acid doped with carbonate hydroxyapatite–egg white
Jamilludin et al. Functionalized cellulose nanofibrils in carbonate-substituted hydroxyapatite nanorod-based scaffold from long-spined sea urchin (Diadema setosum) shells reinforced with polyvinyl alcohol for alveolar bone tissue engineering
Sukhodub et al. Antibacterial and physical characteristics of silver-loaded hydroxyapatite/alginate composites
Nocchetti et al. Alginate microparticles containing silver@ hydroxyapatite functionalized calcium carbonate composites
Karthika Biocompatible iron and copper incorporated nanohydroxyapatite coating for biomedical implant applications
Pemmada et al. Science-based strategies of antibacterial coatings with bactericidal properties for biomedical and healthcare settings
Abraham et al. Effect of Magnesium as Biomaterial in Biodegrdation
Shahid et al. Development of a Ce-doped hydroxyapatite–sodium alginate biocomposite for bone and dental implants
Khodaverdi et al. Chitosan/Bioglass nanocomposites for bone tissue engineering and regenerative medicine: an overview of promising biomaterials

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210525

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20210628

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220208

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220413

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220422

R150 Certificate of patent or registration of utility model

Ref document number: 7083975

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250